ADARx Pharmaceuticals, Inc. Common Stock (ADRX)
Smart-money score is near the top of its range.
ADRX scores higher than 76% of the 11,956 tickers we compare it with (all tickers we score).
As of 10 October 2026, ADARx Pharmaceuticals, Inc. Common Stock (ADRX) scores 56 out of 100 on the Market Census six-factor composite, which puts it at the Above average score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 10 October 2026, and it is not investment advice.
Updated · scores usually change about once a day
Key statistics
Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.
- Relative volume
- —
- 52-week range
- —
- Market cap
- —
- Earnings date
- —
- Volume
- 688,460
- Avg. volume (30d)
- —
- Open
- 17.70
- Previous close
- 17.68
- Day's range (regular session)
- 17.06 – 18.19
The last trade can be an extended-hours trade, so it can sit outside the regular-session range.
Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.
- Beta
- —
- P/E (TTM)
- —
- EPS (TTM)
- —
Score breakdown · six named factors
Each bar is one part of the score, from 0 to 100. Read what the score means.
Premium data held for ADRX
- 51 SEC Form 4 insider transactions in the last 90 daysPremium
Counts of rows Market Census holds for ADRX. A dash in the factor table above means that factor has no data for this ticker — it is not a locked value. Compare plans
What the score says about ADRX right now
ADARx Pharmaceuticals, Inc. Common Stock (ADRX) currently scores 56/100 on the Market Census six-factor composite, at the Above average score level. ADRX is +0.59% on the day and -2.58% over five sessions as of the most recent tick. Above average sits a bit above the middle. The data for ADRX leans good, with some weak spots. ADRX's strongest factor is insider trades at 90/100 — a very strong read on insider buying and selling. Insider filings currently lean toward buying on this name — a plain read of public filings, not a signal to follow. The weakest factor is market mood at 50/100 — middling backdrop. A weak market mood drags every name in the cohort; if ADRX is still scoring well on the composite despite this, the company-specific factors must be doing heavy lifting.
Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.
See ADRX in the scanner
This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).
Recent ADRX news
Latest headlines that name ADARx Pharmaceuticals, one per story, sourced from Market Census’s news feed (Polygon/Massive + Finnhub).
- ADARx Pharmaceuticals Announces the Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares Granted in Its Initial Public OfferingYahoo
- ADARx Pharmaceuticals (ADRX) Moved Higher, But What Is Drawing Attention?Yahoo
- ADARx Pharmaceuticals Announces Pricing of Upsized $446.3 Million Initial Public OfferingYahoo
Saved snapshot; the news and prices on this page can be an hour old or more.
Similar setups in Uncategorized right now
Six uncategorized tickers whose composite scores are closest to ADRX’s 56, all within 1 point.
Sorted by closeness to ADRX’s composite score within Uncategorized. Saved snapshot; can be an hour old or more. Run the full scanner →
Prices delayed about 15 minutes; scores usually change about once a day. Not investment advice — see risk disclosure.